Financial News

Financial Report: Sanofi

Revenues up 3% in the quarter

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Sanofi 4Q Revenues: €8.9 billion (+3%) 4Q Earnings: €811 million (+130%) FY Revenues: €33.8 billion (-1%) FY Earnings: €4.8 billion (+9%) Comments: Sanofi Genzyme (Specialty Care) sales were €1.3 billion in the quarter, up 13% driven by multiple sclerosis products. Sanofi Pasteur GBU revenue grew 4% to €1.4 billion due to strong pediatric combination franchise sales. Diabetes and Cardiovascular GBU sales were €1.7 billion up 4%, with diabetes franchise sales up 2%. Rare Disease sa...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters